Neuronano AB

Our mission is to invent, patent, develop and commercialize a new generation of innovative electrodes for implantation in the brain and spinal cord. The main focus is on developing implantable neural interfaces that outmatch competitors. Neuronano intends to make its technology available to patients by entering into a commercial collaboration with a suitable partner capable of providing and distributing high-quality solutions on a worldwide scale.Our vision is to develop groundbreaking Neuromodulation technologies (alternative or complementary) to pharmacological treatments for e.g. Parkinson's disease, Epilepsia, depression, pain and itch control, control of movements in disabled persons, and also develop a future generation of research instruments for high definition brain research.